Mon. May 25th, 2026
Children in Almajiri Islamic schools in Nigeria standing with cultural attire, representing traditional Islamic education.Almajiri children are students in Nigeria's Islamic schools practicing traditional Islamic education, often living in challenging conditions.
Spread the love
Kevin Na, LIV Golf
Kevin Na at LIV Golf’s UK event in 2024. | Photo by Bradley Collyer/Getty Images

Kevin Na said that anyone who wins a LIV event should then receive an invite to all four majors. Here’s why he’s wrong.

LIV Golf’s Kevin Na wants to guarantee all LIV winners secure a spot in the four major championships, similar to how PGA Tour winners automatically receive invites to Augusta National each year.

Na explained his reasoning in a recent interview with Golf Monthly.

“Winners should be exempt, and I think you take the top 16 players or so. I think if you have a season and you finish inside the top 16, you should be exempt into all four Majors,” Na said.

“A lot of guys who are Major champions and are exempt, they’re going to overlap, so top-10 isn’t enough. I don’t even think top-15 is enough, 16 is a good number. I know The Masters does it so that if you win a golf tournament on the [PGA] Tour, then you get in. I think it should be just the same for LIV.

“If you win a LIV event, there are only 13, then you should be in all the Majors because that’s not easy to do. Plus, you’re going to have multiple winners, so you’ll only get 10 guys who win a tournament in a year. And you know Jon Rahm is going to win one!”

You have to credit Na for sticking up for his tour, but the 41-year-old American is wrong in his assessment. Whoever wins a LIV Golf event should not receive direct access to all four major championships.

For starters, LIV events feature only 54 players each week, a much smaller field size than any other professional golf tournament played around the world. On top of that, LIV has only 54 holes of competition, whereas the PGA Tour, the DP World Tour, and the Asian Tour — along with the four majors — feature 72-hole competitions only. Furthermore, LIV employs a shotgun start, where each group of players begin their round on a separate hole instead of having everyone start on the 1st or 10th holes using staggered tee times.

If that’s not enough, the team element LIV also factors in, as some players have said that their strategy changed when the team competition was close. That was a major reason why the Official World Golf Ranking (OWGR) did not award LIV Golf events OWGR points in the first place: the team play element threatened the integrity of the individual competition.

Now, critics will say, ‘But LIV Golf has so many major champions!’

No doubt they do. But let’s face reality here. Outside of Jon Rahm, Brooks Koepka, Bryson DeChambeau, Cameron Smith, Joaquin Niemann, and Tyrrell Hatton, which LIV player could make a run at winning a major championship? Maybe Sergio Garcia and Louis Oosthuizen? DataGolf currently has all eight of these players ranked among the top 55 in the world, so each of them can still compete at the highest level despite their affiliation with the Saudi-backed circuit. Koepka and DeChambeau have proven that emphatically, winning the 2023 PGA Championship and the 2024 U.S. Open, respectively. They are the only two active LIV players to win a major.

But again, who else could win a major? Sure, a player like Talor Gooch can make a run but his major record is not great. The best finish of his major career came at Augusta in 2022, one month before he joined LIV, when he tied for 14th.

The fact is that LIV remains top-heavy at the moment, with those eight players ranking in a category of their own. Others are either one, well past the prime of their careers, like Dustin Johnson or Phil Mickelson, or two, young and unproven in pro events, like Caleb Surratt or Andy Ogletree.

Nevertheless, the men’s game at the highest level remains in peril. The sport is divided, with major winners competing on both the PGA Tour and LIV Golf, playing together only four times per year, if that. So what’s the solution?

Well, going off of the point Na raised about ‘exemptions,’ the four highest finishers from the LIV Golf season — not otherwise exempt into the four major championships — should receive invitations to The Masters and the PGA Championship, the two events that feature the strongest fields in golf historically. The U.S. Open and The Open are exactly that: open competitions where a player can make it by playing well in qualifiers.

Remember, major champions receive automatic invites to each of the four majors for the subsequent five seasons. Other exemptions exist, too, and they vary depending on the major. However, in the case of simplicity, we can use the five-year rule as an example. For instance, Phil Mickelson won the PGA Championship in 2021, so he can still play in all four majors in 2025. If Mickelson finished among the top four in the final standings, then the next highest finisher not otherwise exempt would receive the nod.

Here’s who would receive this distinction this year if this mechanism was applied: Joaquin Niemann, Sergio Garcia, Tyrrell Hatton, and Louis Oosthuizen.

Rahm finished first in the rankings but will play in majors for years to come, thanks to his wins at the 2021 U.S. Open and the 2023 Masters. Niemann, Garcia, and Hatton finished second, third, and fourth, respectively, thus gaining entry into all four majors. Of those three, only Garcia has won a major, doing so at the 2017 Masters. Koepka finished fifth but has won five majors in his career, so he will not be skipping out on any of them soon. And then Oosthuizen, who won the 2010 Open at St. Andrews, finished sixth so that he would earn the fourth and final spot.

What do you make of this idea? Is it a sufficient compromise to Na’s proclamation? Or should LIV players receive the benefit of the doubt? We would love to hear your thoughts in the comments below.

Jack Milko is a golf staff writer for SB Nation’s Playing Through. Follow him on X @jack_milko.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.